FI920206A0 - Medicinsk anvaendning, medicinskt foerfarande och preparat. - Google Patents

Medicinsk anvaendning, medicinskt foerfarande och preparat.

Info

Publication number
FI920206A0
FI920206A0 FI920206A FI920206A FI920206A0 FI 920206 A0 FI920206 A0 FI 920206A0 FI 920206 A FI920206 A FI 920206A FI 920206 A FI920206 A FI 920206A FI 920206 A0 FI920206 A0 FI 920206A0
Authority
FI
Finland
Prior art keywords
pct
antibiotic
medicinskt
medicinsk
preparat
Prior art date
Application number
FI920206A
Other languages
English (en)
Inventor
Pekka Untamo Heino
Original Assignee
Pekka Untamo Heino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pekka Untamo Heino filed Critical Pekka Untamo Heino
Priority to FI920206A priority Critical patent/FI920206A0/fi
Publication of FI920206A0 publication Critical patent/FI920206A0/fi
Priority to US08/256,508 priority patent/US5607671A/en
Priority to AT93902271T priority patent/ATE174513T1/de
Priority to PCT/FI1993/000016 priority patent/WO1993013795A1/en
Priority to DE69322659T priority patent/DE69322659T2/de
Priority to EP93902271A priority patent/EP0671942B1/en
Priority to ES93902271T priority patent/ES2129078T3/es
Priority to DK93902271T priority patent/DK0671942T3/da
Priority to GR990400783T priority patent/GR3029699T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/50Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/56Protease inhibitors from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01004Amidase (3.5.1.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02006Beta-lactamase (3.5.2.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Cephalosporin Compounds (AREA)
FI920206A 1992-01-17 1992-01-17 Medicinsk anvaendning, medicinskt foerfarande och preparat. FI920206A0 (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI920206A FI920206A0 (fi) 1992-01-17 1992-01-17 Medicinsk anvaendning, medicinskt foerfarande och preparat.
US08/256,508 US5607671A (en) 1992-01-17 1993-01-18 Medical use, a medical method and a pharmaceutical preparation
AT93902271T ATE174513T1 (de) 1992-01-17 1993-01-18 Pharmazeutische zubereitung enthaltend eine beta-lactam antibiotikum abbauende verbindung, und deren verwendung
PCT/FI1993/000016 WO1993013795A1 (en) 1992-01-17 1993-01-18 Medical use, a medical method and a pharmaceutical preparation
DE69322659T DE69322659T2 (de) 1992-01-17 1993-01-18 Pharmazeutische zubereitung enthaltend eine beta-lactam antibiotikum abbauende verbindung, und deren verwendung
EP93902271A EP0671942B1 (en) 1992-01-17 1993-01-18 Pharmaceutical preparation comprising a beta-lactam antibiotic degrading compound, and use thereof
ES93902271T ES2129078T3 (es) 1992-01-17 1993-01-18 Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion.
DK93902271T DK0671942T3 (da) 1992-01-17 1993-01-18 Farmaceutisk præparat omfattende en beta-lactamantibiotikumnedbrydende forbindelse og anvendelse deraf
GR990400783T GR3029699T3 (en) 1992-01-17 1999-03-16 Medical use, a medical method and a pharmaceutical preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI920206A FI920206A0 (fi) 1992-01-17 1992-01-17 Medicinsk anvaendning, medicinskt foerfarande och preparat.

Publications (1)

Publication Number Publication Date
FI920206A0 true FI920206A0 (fi) 1992-01-17

Family

ID=8534042

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920206A FI920206A0 (fi) 1992-01-17 1992-01-17 Medicinsk anvaendning, medicinskt foerfarande och preparat.

Country Status (9)

Country Link
US (1) US5607671A (fi)
EP (1) EP0671942B1 (fi)
AT (1) ATE174513T1 (fi)
DE (1) DE69322659T2 (fi)
DK (1) DK0671942T3 (fi)
ES (1) ES2129078T3 (fi)
FI (1) FI920206A0 (fi)
GR (1) GR3029699T3 (fi)
WO (1) WO1993013795A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332687A (en) * 1996-05-09 2000-05-26 Sankyo Co use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
FI20020332A0 (fi) * 2002-02-20 2002-02-20 Heino Pekka Untamo Valmiste ja menetelmä painon pudottamiseksi
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843301B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
JP2008529996A (ja) * 2005-02-09 2008-08-07 ダ・ボルテラ 活性因子の大腸送達
FI119190B (fi) 2006-06-21 2008-08-29 Ipsat Therapies Oy Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi
US8273376B2 (en) * 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
US20080124279A1 (en) * 2006-11-17 2008-05-29 Antoine Andremont Colonic delivery using Zn/pectin beads with a Eudragit coating
KR20100020480A (ko) * 2007-05-21 2010-02-22 페노믹스 코포레이션 Dpp-iv 저해제를 위한 안정한 약제학적 제제
ITBO20080297A1 (it) * 2008-05-16 2009-11-17 Archimede R & D S R L Composizione enzimatica per ridurre il rilascio di principi attivi farmaceutici nell'ambiente.
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
ITMI20121715A1 (it) * 2012-10-11 2014-04-12 Bioikos Ambiente S R L Composizioni farmaceutiche con ridotto impatto ambientale
AU2015247382B2 (en) 2014-04-17 2020-04-23 Theriva Biologics, Inc. Beta-lactamases with improved properties for therapy
CN106574273B (zh) 2014-08-28 2021-07-02 合成生物制品有限公司 β-内酰胺酶的基于大肠杆菌的生产
CN107148473B (zh) 2014-10-08 2021-08-06 合成生物制品有限公司 β-内酰胺酶制剂及其用途
FR3027307B1 (fr) * 2014-10-16 2016-11-04 Azurrx Sas Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
JP6810697B2 (ja) 2015-02-23 2021-01-13 シンセティック・バイオロジクス・インコーポレイテッド 腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ
US10709773B2 (en) 2015-03-06 2020-07-14 Synthetic Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
US10982205B2 (en) 2016-02-23 2021-04-20 Da Volterra Beta-lactamase variants
WO2017144495A1 (en) 2016-02-23 2017-08-31 Da Volterra Beta-lactamase variants
EP3701022B1 (en) 2017-10-25 2023-03-01 Da Volterra Beta-lactamase variants
JP2022532162A (ja) * 2019-05-06 2022-07-13 シンセティック・バイオロジクス・インコーポレイテッド 移植片対宿主病の処置のためのβ-ラクタマーゼ組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613624B1 (fr) * 1987-04-10 1990-11-23 Roussy Inst Gustave Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
CS275231B2 (en) * 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle

Also Published As

Publication number Publication date
GR3029699T3 (en) 1999-06-30
EP0671942B1 (en) 1998-12-16
DK0671942T3 (da) 1999-08-23
DE69322659D1 (de) 1999-01-28
US5607671A (en) 1997-03-04
WO1993013795A1 (en) 1993-07-22
EP0671942A1 (en) 1995-09-20
DE69322659T2 (de) 2000-01-05
ATE174513T1 (de) 1999-01-15
ES2129078T3 (es) 1999-06-01

Similar Documents

Publication Publication Date Title
FI920206A0 (fi) Medicinsk anvaendning, medicinskt foerfarande och preparat.
Suh et al. Quinolones
MY124714A (en) Enzyme treatment
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
ATE355076T1 (de) Zusammensetzungen und methoden zur systemischen verabreichung von oralen impfstoffen und therapeutischen wirkstoffen
NO20014507L (no) Legemiddel for behandling av sukkersyke
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
HUP9904308A2 (hu) A mupirocin alkalmazása a nasopharynxnak patogén organizmusokkal történő kolonizációjához társuló bakteriális fertőzések kezelésére szolgáló gyógyszerkészítmény előállítására
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
RU94016167A (ru) Фармацевтическая композиция, способы доставки биологически активного вещества, способы лечения, способы стимулирования
ME00578A (en) Use of gastrointestinal lipase inhibitors
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
Rosenberg et al. Antibiotic TA: an adherent antibiotic
CN1285745A (zh) 酶前体药物作为抗感染剂的应用
DE69933925D1 (de) Verbesserte methode zur eradikation von helicobacter pylori
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
RU95118193A (ru) Штамм бактерий bifidobacterium coturnix, используемый для приготовления пробиотического препарата для птицеводства и ветеринарии
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань